Polymer size affects biodistribution and placental accumulation of the drug delivery biopolymer elastin-like polypeptide in a rodent pregnancy model.

Polymer size affects biodistribution and placental accumulation of the drug delivery biopolymer elastin-like polypeptide in a rodent pregnancy model.
复制标题

DOI:
10.1016/j.placenta.2018.10.005
复制
发表时间:
2018-12
期刊:
影响因子:
3.8
通讯作者:
Bidwell GL 3rd
Bidwell GL 3rd
中科院分区:
医学3区
文献类型:
--
作者:
Kuna M;Waller JP;Logue OC;Bidwell GL 3rd

文献摘要

参考文献

被引文献

相似文献

Fusion of therapeutic agents to Elastin-like Polypeptide (ELP) is a novel drug delivery strategy for prevention of placental drug transfer. Previous studies have used a 60 kDa ELP tag for this purpose. However, placental transfer of ELP may be size dependent. The goal of this study was to measure the effects of ELP polymer size on pharmacokinetics, biodistribution, and placental transfer of ELP. Three ELPs ranging from 25 to 86 kDa (4.1 to 6.8 nm hydrodynamic radius) were fluorescently labeled and administered by i.v. bolus to pregnant Sprague Dawley rats on gestational day 14. Plasma levels were monitored for 4h, organ levels and placental transfer determined by ex vivo fluorescence imaging, and placental localization determined by confocal microscopy. Increasing ELP size resulted in slower plasma clearance and increased deposition in all major maternal organs, except in the kidneys where an opposite effect was observed. Placental levels increased with an increase in size, while in the pups, little to no ELP was detected. Pharmacokinetics and biodistribution of ELPs during pregnancy are size dependent, but all ELPs tested were too large to traverse the placental barrier. These studies verify that ELP fusion is a powerful method of modulating half-life and preventing placental transfer of cargo molecules. The tunable nature of the ELP sequence makes it ideal for drug delivery applications during pregnancy, where it can be used to target drugs to the mother while preventing fetal drug exposure.
一种母体隔离的生物聚合物稳定的血管内皮生长因子(VEGF)嵌合体,用于治疗先兆子痫。
DOI: 10.1161/jaha.117.007216
发表时间: 2017-12-08
影响因子: 5.4
作者:
Logue OC;Mahdi F;Chapman H;George EM;Bidwell GL 3rd
通讯作者: Bidwell GL 3rd
DOI: 10.1016/j.ajog.2016.03.001
发表时间: 2016-07
影响因子: 9.8
作者:
Ilekis JV;Tsilou E;Fisher S;Abrahams VM;Soares MJ;Cross JC;Zamudio S;Illsley NP;Myatt L;Colvis C;Costantine MM;Haas DM;Sadovsky Y;Weiner C;Rytting E;Bidwell G
通讯作者: Bidwell G
DOI: 10.1371/journal.pone.0055104
发表时间: 2013
期刊: PloS one
影响因子: 3.7
作者:
Bidwell GL 3rd;Perkins E;Hughes J;Khan M;James JR;Raucher D
通讯作者: Raucher D
DOI: 10.1093/jnci/djj070
发表时间: 2006-03-01
影响因子: 10.3
作者:
Dreher, MR;Liu, WG;Chilkoti, A
通讯作者: Chilkoti, A
DOI: 10.1073/pnas.1214518110
发表时间: 2013-02-19
影响因子: 11.1
作者:
Amiram, Miriam;Luginbuhl, Kelli M.;Chilkoti, Ashutosh
通讯作者: Chilkoti, Ashutosh